Position in IBRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,497,065
+$9,657,625 QoQ
Shares Held
1,890,100
-22.7% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Derivatives in IBRX
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,454,232
PutShares
189,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. IBRX ranks #20 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in IBRX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,497,065 | 1,890,100 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,454,232 | 189,600 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $4,839,440 | 2,444,163 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,282,107 | 927,687 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $316,800 | 120,000 | Put | Sole | 2026-02-27 | |
| 2025-06-30 | $2,217,318 | 839,894 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $1,098,755 | 365,035 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $1,014,999 | 396,484 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $1,343,053 | 361,036 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $1,003,540 | 158,788 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,071,042 | 385,669 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $1,059,501 | 197,300 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $2,407,315 | 479,545 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $74,990 | 44,373 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $168,103 | 60,469 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $75,144 | 41,288 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $1,299,770 | 256,365 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $1,257,559 | 253,030 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $40,409 | 10,863 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $65,306 | 11,641 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||